CGEM - Cullinan Oncology Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-09-16)
Last
 6.29		 Change
 ⇓ -0.06   (-0.94%)		 Volume
  457,678
Open
 6.33		 High
 6.47		 Low
 6.24
8EMA (Daily)
 6.63		 40EMA (Daily)
 7.35		 50EMA (Daily)
 7.45		 STO (Daily)
 4.935		 MACD Hist (Daily)
 -0.198
8EMA (Weekly)
 7.122		 40EMA (Weekly)
 9.10		 50EMA (Weekly)
 9.69		 STO (Weekly)
 19.997		 MACD Hist (Weekly)
 -0.002
Company Profile
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com